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The study aimed at screening synthetic compounds for 
pharmacological activity. The anthelmintic activity of 3-
benzyl-2-(4'-substituted phenyl)-4(5H)-(4''-nitrophenyl 
amino)-1, 3-oxazolidines 6a-e compounds was evaluated 
by Passive avoidance test. The purity of the synthesized 
compounds was characterized by means of IR, 1H-NMR, 
mass spectral and elemental analysis.  
 




Parasitic nematodes cause significant problems to the 
health and life of many plants and animals, and also of 
humans. Gastrointestinal parasites create a serious threat to 
the production of livestock in developing nations1. Despite 
the fact of development of anthelmintic resistance in 
parasites of high economic significance, chemotherapy is 
still the most widely used option for the control of 
helminthes. Helminthes parasite infections are global 
problems with serious social and economic repercussions in 
the Third World countries2. The diseases affect the health 
status of a large fraction of the human population as well as 
animals. Some type of dangerous helminthes infections like 
filariasis has only a few therapeutic modalities at present3. 
The continuous and long-term reliance on a small range of 
compounds has led to the development of drug resistance in 
many helminthic strains. In addition, after treatment with 
albendazole ormebendazole, several side effects have been 
reported in hosts such as gastrointestinal symptoms 
(epigastric pain, diarrhea, nausea, vomiting), nervous 
system symptoms (headache, dizziness), and allergic 
phenomena (edema, rashes, urticaria). Some anthelmintic 
drugs, such as praziquantel and albendazole, are 
contraindicated for certain groups of patients like pregnant 
and lactating woman. These drugs have also to be used 
with caution in hepatitis patients and in children below 2 
years of age4. Following the discovery of oxazolidine 
derivatives, numerous structural modifications have been 
made to the oxazolidine nucleus to increase the 
anthelmintic potency.  
 
MATERIALS AND METHODS 
Materials 
Synthetic starting material, reagents and solvents were of 
analytical reagent grade or of the highest quality 
commercially available and were purchased from Aldrich 
Chemical Co., Merck Chemical Co. and were dried when 
necessary. 
The melting points were taken in open capillary tube and 
are uncorrected. IR spectra were recorded with KBr pellets 
(ABB Bomem FT-IR spectrometer MB 104 ABB Limited 
Bangaluru, India). Proton (1H) NMR spectra (Bruker 400 
NMR spectrometer Mumbai, India) were recorded with 
TMS as internal references. Mass spectral data were 
recorded with a quadrupol mass spectrometer (Shimadzu 
GC MS QP 5000, Chennai, India), and microanalyses were 
performed using a vario EL V300 elemental analyzer 
(Elemental Analysensysteme GmbH Chennai, India). The 
purity of the compounds was checked by TLC on pre-
coated SiO2 gel (HF254, 200 mesh) aluminium plates 
(E.Merck) using ethyl acetate: benzene (1:3) and visualized 
in UV chamber. IR, 1H-NMR, mass spectral datas and 
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General Procedures. The target novel oxazolidine 
derivatives were synthesized by previously reported 
method5 (Zarghi et al., 2007). Accordingly, benzylamine 1 
was treated with an equimolar amount of substituted 
benzaldehyde 2 and an hydroxy acetic acid 3 in dry toluene 
under reflux 24- 48 h to give 3-benzyl-2-(4’-substituted 
phenyl)-1,3-oxazolidine-4(5H)-one 4, further its treat with 
thionyl chloride and DMF to get chloro derivative 5  3-
benzyl-2-(4'-substituted phenyl)-4(5H)-chloro-1,3-
oxazolidine and then coupled with p-nitro anilines in DMF 
at 800C and quenched in ice-water to get the product were 
separated by filtration, vaccum dried and recrystallized 
from warm ethanol to yields 3-benzyl-2-(4'-substituted 
phenyl)-4(5H)-(4''-nitrophenyl amino)-1,3-oxazolidines 6a-




Yellow solid; Yield: 78%; mp. 183-185°C, IR : 3476 (O-
H), 3096 (Ar-CH), 1728 (C=O), 1468 (C=C) cm-1; 1H-
NMR (CDCl3): δ 9.84 (s, 1H, Ar-OH), 6.96-7.54 (m, 9H, 
Ar-H), 6.67 (s, 1H, -CH), 4.12-4.62 (m, 4H, 2 × CH2); EI-
MS (m/z, %): 269 [M]+; (Calcd for C16H15NO3; 269.3). 
Anal. Calcd for C16H15NO3, C, 71.36; H, 5.61; N, 5.20; 
Found: C, 71.41; H, 5.69; N, 5.27. 
3-benzyl-2-(4'-hydroxy phenyl)-4(5H)-(4''-nitrophenyl 
amino)-1,3-oxazolidines (6a) 
Pale yellow solid; Yield: 76%; mp. 156-158°C, IR : 3464 
(O-H), 3027 (Ar-CH), 1494 (C=C), 1564 (N=O), 1306 (N-
H bending), 3396 (N-H stretching) cm-1; 1H-NMR (CDCl3): 
δ 9.87 (s, 1H, Ar-OH), 6.76-7.27 (m, 13H, Ar-H), 6.31 (s, 
2H, -CH),  7.21 (s, 1H, N-H),  3.44-3.67 (m, 4H, 2 × CH2); 
EI-MS (m/z, %): [M]+ 391; (Calcd for C22H21N3O4; 
391.42). Anal. Calcd for C22H21N3O4; C, 67.51; H, 5.41; N, 
10.74; Found: C, 67.57; H, 5.44; N, 10.79. 
3-benzyl-2-(4'-methoxy phenyl)-4(5H)-(4''-nitrophenyl 
amino)-1,3-oxazolidines (6b) 
White solid; Yield: 89%; mp. 184-186°C, IR : 3026 (Ar-
CH), 1524 (C=C), 1567 (N=O), 1316 (N-H bending), 3319 
(N-H stretching) cm-1;  1H-NMR (CDCl3): δ  6.72-7.23 (m, 
13H, Ar-H), 6.36 (s, 2H, -CH),  3.78 (s, 3H –OCH3), 7.15 
(s, 1H, N-H),  3.54-3.72 (m, 4H, 2 × CH2); EI-MS (m/z, 
%): [M]+ 405; (Calcd for C23H23N3O4; 405.45). Anal. 
Calcd for C23H23N3O4; C, 68.13; H, 5.72; N, 10.36; Found: 
C, 68.19; H, 5.76; N, 10.31. 
3-benzyl-2-(4'-methyl phenyl)-4(5H)-(4''-nitrophenyl 
amino)-1,3-oxazolidines (6c) 
Paleyellow solid; Yield: 77%; mp. 170-123°C, IR : 3027 
(Ar-CH), 1413 (C=C), 1570 (N=O), 1334 (N-H bending), 
3313 (N-H stretching) cm-1; 1H-NMR (CDCl3): δ  6.62-
7.18 (m, 13H, Ar-H), 6.29 (s, 2H, -CH),  3.69 (s, 3H –
CH3), 7.21 (s, 1H, N-H),  3.49-3.63 (m, 4H, 2 × CH2); EI-
MS (m/z, %): [M]+ 389; (Calcd for C23H23N3O3; 389.45). 
Anal. Calcd for C23H23N3O3; C, 70.93; H, 5.95; N, 10.79; 
Found: C, 70.95; H, 5.91; N, 10.83. 
3-benzyl-2-(4'-nitro phenyl)-4(5H)-(4''-nitrophenyl 
amino)-1,3-oxazolidines (6d) 
Pale solid; Yield: 71%; mp. 181-183°C, IR : 3027 (Ar-CH), 
1413 (C=C), 1546 (N=O), 1334 (N-H bending), 3313 (N-H 
stretching) cm-1; 1H-NMR (CDCl3): δ  6.79-7.33 (m, 13H, 
Ar-H), 6.21 (s, 2H, -CH), 7.27 (s, 1H, N-H),  3.46-3.78 (m, 
4H, 2 × CH2); EI-MS (m/z, %): [M]+ 420; (Calcd for 
C22H20N4O5; 420.42). Anal. Calcd for C22H20N4O5; C, 




Brown solid; Yield: 81%; mp. 184-186°C, IR : 3026 (Ar-
CH), 1524 (C=C), 1532 (N=O), 1316 (N-H bending), 3319 
(N-H stretching), 749 (C-Cl) cm-1;  1H-NMR (CDCl3): δ  
6.71-7.37 (m, 13H, Ar-H), 6.34 (s, 2H, -CH), 7.31 (s, 1H, 
N-H),  3.48-3.81 (m, 4H, 2 × CH2);  EI-MS (m/z, %): [M]+ 
409; (Calcd for C22H20ClN3O3; 409.87). Anal. Calcd for 
C22H20ClN3O3; C, 64.47; H, 4.92; N, 10.25; Found: C, 
64.43; H, 4.99; N, 10.29. 
Animals 
Indian adult ethworms (pheretima posthuma) were used to 
study anthelmintic activity. The earthworms were collected 
from moist soil and washed to remove all fecal materials. 
The earthworms in 3-5 cm. in length and 0.1-0.1-2 cm in 
width were used for all experimental protocol. The 
earthworm resembles both anatomically and 
physiologically to the intestinal roundworms parasites of 
human beings, hence can be used to study anthelmintic 
activity6. 
Antihelmintic activity 
The newly synthesized compounds were tested for 
anthelmintic activity [1]. Pheretima posthuma (earthworm 
obtained from Lalbagh Botanical Garden, Bangalore) of 
nearly equal size (6cm ± 1) were selected randomly for 
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laboratory condition before experimentation. The 
earthworms were divided into four groups of six 
earthworms in each. Albendazole diluted to with normal 
saline solution to obtained 0.1% w/v, 0.2% w/v, 0.5% w/v 
and 1% w/v served as standard and poured into petridishes. 
The synthesized compounds were prepared in minimal 
quantity of DMSO and diluted to prepare four 
concentrations i.e. 0.1% w/v, 0.2% w/v, 0.5% w/v and 1% 
w/v for each compound. Normal saline serve as control. Six 
earthworms nearly equal size (6cm ± 1) are taken for each 
concentration and placed in petridishes at room 
temperature10. The time taken for complete paralysis and 
death are recorded. The mean paralysis time and mean 
lethal time for each sample was calculated (each reading 
taken in triplicate). The time taken for worms to become 
motionless was noted as paralysis time and to ascertain 
death, each worm was frequently applied with external 
stimuli which stimulates +and induce movement in the 
earthworms, if alive11. 
 
RESULTS AND DISCUSSION 
Chemistry  
The synthesized series of heterocycles, 6a-e by the reaction 
of 5 with appropriate p –nitro aniline in the presence of 
DMF as presented in Scheme 1. The IR, 1H-NMR, mass 
spectroscopy and elemental analysis for the new compound 
is in accordance with the assigned structures. The IR 
spectra of compounds 4 showed stretching bands of keto 
group at 1728 cm-1. In 5, stretching bands of chloro group 
at 749 cm-1 is evidence to conversion of oxazolidinone. The 
title compounds 6a-e stretching and bending NH bands 
appear at 3300-3400 cm-1, 1300-1350 cm-1 respectively. 
The recorded IR spectrum of representative compounds 6a-
e showed missing of chloro group bands. This clearly 
envisages that the chloro group of 5 is converted into 
secondary NH. The proton magnetic resonance spectra of 
oxazolidine and their corresponding derivatives have been 
recorded in CDCl3. In this 6a-e NH signal of 3-benzyl-2-
(4'-substituted phenyl)-4(5H)-(4''-nitrophenyl amino)-1,3-
oxazolidines moiety appear at 7.26 (s), 7.15 (s), 7.21 (s), 
7.27 (s), 7.34 (s), ppm respectively. The position and 
presence of NH signal in the 1H-NMR spectra of final 
compounds conforms the secondary NH proton in 
oxazolidine moiety. This clearly envisages that 
oxazolidine-4(5H)-one moiety involve in 4(5H)-chloro-1,3-
oxazolidine and further (4''-nitrophenyl amino)-1,3-
oxazolidines formation. All these observed facts clearly 
demonstrate that the 4th position of keto group in 
oxazolidine ring is converted into secondary amino group 
as indicated in scheme 1 and conforms the proposed 
structure (6a -e).  
 
Antihelmintic activity 
The anthelmintic screening of the compounds 3-benzyl-2-
(4'-substituted phenyl)-4(5H)-(4''-nitrophenyl amino)-1, 3-
oxazolidines 6a-e showed an excellent activity than 
standard albendazole. A closer inspection of data from this 
table indicates that compounds hydroxy, nitro and chloro 
substitution of oxazolidine having activity than other 
compounds compared with standard. Compounds methoxy 
and methyl substitution showed very less activity. The 
transformation order of screened compounds is 6a >6d >6e 
>6c >6b and albendazole were used as standard 
anthelmintic drug.  
The observed data on the anthelmintic activity of the 
synthesized compounds and standard drugs are given in 


















































































































Table1. Anthelmintic activities of 3-benzyl-2-(4'-substituted phenyl)-4(5H)-(4''-nitrophenyl amino)-1, 3-oxazolidines. 
Values are expressed in mean ±SEM 
 
Compounds Time in min. (mean ± SEM) for paralysis Time in min. (mean ± SEM) for death 
 Concentration (%) Concentration (%) 
0.1 0.2 0.5 1 0.1 0.2 0.5 1 
6a 2.120± 0.107 2.526±0.126 2.130±0.016 1.217±0.121 4.417±0.014 3.120±0.240 3.123±0.014 1.425±0.214 
6b 5.123±0.118 4.145±0.171 3.812±0.177 2.316± 0.101 5.150± 0.122 4.142± 0.329 4.125± 0.321 2.120± 0.138 
6c 5.318±0.015 4.222±0.139 3.212±0.042 2.512±0.011 6.912± 0.126 6.122±0.015 4.727±0.120 3.289± 0.120 
6d 3.133 ± 0.027 2.418±0.015 1.713±0.136 1.243± 0.016 3.432±0.123 2.418±0.172 2.415±0.107 1.193±0.019 
6e 2.127±0.167 2.027±0.192 1.522±0.031 0.831±0.141 3.110± 0.047 2.518±0.092 1.810±0.135 1.125± 0.046 
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